UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death

Clinical cancer research, 2020-03, Vol.26 (5), p.1126-1134

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Cancer immunology research, 2018-04, Vol.6 (4), p.481-493

2018

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders

Scientific reports, 2021-04, Vol.11 (1), p.8775-8775, Article 8775

2021

Link zum Volltext

Verfügbarkeit prüfen

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence

Cancers, 2021-09, Vol.13 (19), p.4914

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

Oncoimmunology, 2022, Vol.11 (1), p.2066767-2066767

2022

Link zum Volltext

Verfügbarkeit prüfen

Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients

Seminars in arthritis and rheumatism, 2023-12, Vol.63, p.152263-152263, Article 152263

2023

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Viruses for the Treatment of Metastatic Melanoma

Current treatment options in oncology, 2020-03, Vol.21 (4), p.26-26, Article 26

2020

Link zum Volltext

Verfügbarkeit prüfen

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Scientific reports, 2021-02, Vol.11 (1), p.2809-2809, Article 2809

2021

Link zum Volltext

Verfügbarkeit prüfen

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer research (Chicago, Ill.), 2020-03, Vol.80 (5), p.1078-1087

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Clinical cancer research, 2019-04, Vol.25 (8), p.2494-2502

2019

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma

American journal of clinical dermatology, 2020-02, Vol.21 (1), p.1-11

2020

Link zum Volltext

Verfügbarkeit prüfen

IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy

Cell systems, 2018-07, Vol.7 (1), p.92-103.e4

2018

Link zum Volltext

Verfügbarkeit prüfen

Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform

International journal of radiation oncology, biology, physics, 2017-09, Vol.99 (1), p.191-201

2017

Link zum Volltext

Verfügbarkeit prüfen

FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab

Clinical nuclear medicine, 2020-04, Vol.45 (4), p.267

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas

Cancer Immunology, Immunotherapy, 2015-09, Vol.64 (9), p.1193-1203

2015

Link zum Volltext

Verfügbarkeit prüfen

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

Cancer research communications, 2024-04, Vol.4 (4), p.1100-1110

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Current oncology reports, 2018-12, Vol.20 (12), p.100-100, Article 100

2018

Link zum Volltext

Verfügbarkeit prüfen

Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9884-9891

2008

Link zum Volltext

Verfügbarkeit prüfen

Malignant portal vein tumor thrombosis (PVTT) in patients with hepatocellular (HCC) carcinoma: Insights from a Western single-institutional cohort

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.552-552

2023

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic t lymphocyte (CTL) to macrophage ratio to predict survival in stage II-III melanoma: Validation in a second cohort

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21595-e21595

2021

Link zum Volltext

Verfügbarkeit prüfen

Using tumor growth rate to inform treatment efficacy in pancreatic adenocarcinoma: From the metastatic to the neoadjuvant setting

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.726-726

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2798-2798

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21610-e21610

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4068: Radiation, immune checkpoint inhibition, and modulation of the tumor immune microenvironment promotes immunologic rejection of established HPV-associated tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4068-4068

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaImmunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders

Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma

Urine Proteomics Link Complement Activation with Interstitial Fibrosis/Tubular Atrophy in Lupus Nephritis Patients

Oncolytic Viruses for the Treatment of Metastatic Melanoma

Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma

IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy

Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform

FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease

Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma

Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma

Malignant portal vein tumor thrombosis (PVTT) in patients with hepatocellular (HCC) carcinoma: Insights from a Western single-institutional cohort

Cytotoxic t lymphocyte (CTL) to macrophage ratio to predict survival in stage II-III melanoma: Validation in a second cohort

Using tumor growth rate to inform treatment efficacy in pancreatic adenocarcinoma: From the metastatic to the neoadjuvant setting

Abstract 2798: High density of CD68+HLA-DR- macrophages in the stroma of primary melanoma correlates with an unfavorable immune microenvironment as assessed by Digital Spatial Profiling

Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma

Abstract 4068: Radiation, immune checkpoint inhibition, and modulation of the tumor immune microenvironment promotes immunologic rejection of established HPV-associated tumors

Aktive Filter

Suchergebnisse filtern